NG
IPXL

NatWest Group’s Impax Laboratories, Inc. IPXL Stock Holding History

NatWest Group’s Portfolio IPXL Stock Details IPXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-26,249
Closed -$924K – 381
2015
Q3 		$924K Buy
26,249
+1,252
+5% +$56.4K 0.02% 202
2015
Q2 		$1.15M Sell
24,997
-1,252
-5% -$59.4K 0.01% 184
2015
Q1 		$1.23M Sell
26,249
-3,591
-12% -$143K 0.02% 203
2014
Q4 		$945 Sell
29,840
-6,354
-18% -$186K 0.01% 220
2014
Q3 		$858 Sell
36,194
-439
-1% -$11.2K 0.01% 277
2014
Q2 		$1.1M Sell
36,633
-4,352
-11% -$117K 0.05% 254
2014
Q1 		$1.08M Sell
40,985
-10,639
-21% -$266K 0.05% 235
2013
Q4 		$1.3M Sell
51,624
-3,122
-6% -$69.6K 0.03% 366
2013
Q3 		$1.12M Sell
54,746
-307
-0.6% -$6.34K 0.03% 393
2013
Q2 		$1.1M Buy
+55,053
New +$977K 0.02% 453

Other funds holding IPXL

HP
Hound Partners New York $799M AUM 9.54% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
AG
Aravt Global New York $11.3M AUM 3.78% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
PCM
Pennant Capital Management Summit, New Jersey $212M AUM 19.37% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

NatWest Group's IPXL Position: Q4 2015 in Review

NatWest Group sold out of Impax Laboratories, Inc. (IPXL) in Q4 2015, closing a stake of 26,249 shares — an estimated $924K sold.

NatWest Group first reported a position in IPXL in Q2 2013 and held it in 10 quarters. The position peaked at $1.3M in Q4 2013. 196 funds tracked by Wall St. Rank hold IPXL as of Q4 2015.

  • NatWest Group reported no remaining Impax Laboratories, Inc. position as of Q4 2015 after selling out during the quarter.
  • NatWest Group sold 26,249 Impax Laboratories, Inc. shares in Q4 2015, an estimated $924K.
  • NatWest Group first reported a position in Impax Laboratories, Inc. in Q2 2013 and held it in 10 quarters.
  • NatWest Group's Impax Laboratories, Inc. position peaked at $1.3M in Q4 2013.
  • 196 funds tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q4 2015.

Based on NatWest Group's 13F filing for Q4 2015, filed 16 Feb 2016.